FOI 5681- Data on metastatic breast cancer patients and treatments

Date: 17 September 2019 to 17 September 2022

  1. Within your health trust how many metastatic breast cancer patients are currently [within the past 6 months] being treated, with any therapy, surgery or palliative care.
  2. Within your health trust how many breast cancer patients are currently [within the past 6 months] being treated for bone metastases with the following treatments;
  • disodium pamidronate (Aredia)
  • ibandronic acid or ibandronate (Bondronat)
  • sodium clodronate (Bonefos, Clasteon, Loron)
  • zoledronic acid or zoledronate (Zometa)
  • denosumab (Xgeva)
  1. Within your health trust how many breast cancer patients are currently [within the past 6 months] being treated with adjuvant therapy with the following treatments;
  • disodium pamidronate (Aredia)
  • ibandronic acid or ibandronate (Bondronat)
  • sodium clodronate (Bonefos, Clasteon, Loron)
  • zoledronic acid or zoledronate (Zometa)
  1. Within your health trust how many metastatic lung cancer patients are currently [within the past 6 months] being treated with any therapy, surgery or palliative care.
  2. Within your health trust how many lung cancer patients are currently [within the past 6 months] being treated for bone metastases with the following treatments;
  • disodium pamidronate (Aredia)
  • ibandronic acid or ibandronate (Bondronat)
  • sodium clodronate (Bonefos, Clasteon, Loron)
  • zoledronic acid or zoledronate (Zometa)
  • denosumab (Xgeva)
  1. Within your health trust how many metastatic renal cell cancer patients are currently [within the past 6 months] being treated with any therapy, surgery or palliative care.
  2. Within your health trust how many renal cell carcinoma [RCC] patients are currently [within the past 6 months] being treated for bone metastases with the following treatments;
  • disodium pamidronate (Aredia)
  • ibandronic acid or ibandronate (Bondronat)
  • sodium clodronate (Bonefos, Clasteon, Loron)
  • zoledronic acid or zoledronate (Zometa)
  • denosumab (Xgeva)
  • Request ID:
    FOI 5681
  • Category:
    Patient - Activity Data
  • Response:

    Response attached